Effect of pirfenidone on wound healing in lung transplant patients
Abstract Background The drug pirfenidone has been shown to slow the progression and decrease mortality of idiopathic pulmonary fibrosis (IPF). Its exact mechanism is unknown, but it likely inhibits pro-fibrotic cytokine transforming growth factor beta, a known contributor to wound healing. We evalua...
Main Authors: | Amber Mortensen, Lauren Cherrier, Rajat Walia |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2018-06-01
|
Series: | Multidisciplinary Respiratory Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40248-018-0129-4 |
Similar Items
-
Reactivation pulmonary tuberculosis in two patients treated with pirfenidone
by: Mohammad Khan, et al.
Published: (2017-01-01) -
Comparative study between pirfenidone and traditional drugs in treatment of idiopathic pulmonary fibrosis
by: Ramadan M Nafee, et al.
Published: (2019-01-01) -
Perils with Pirfenidone and “the tuberculosis link”
by: Madhav H Hande, et al.
Published: (2019-01-01) -
Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
by: Myung Jin Song, et al.
Published: (2021-05-01) -
Antifibrotic activities of pirfenidone in animal models
by: L. Pan, et al.
Published: (2011-06-01)